Characteristic | Total patient (n = 256) | IIH witout BN (n = 191) | IIH with BN (n = 65) | P | Validation set (n = 76) | Training set (n = 180) | P |
---|---|---|---|---|---|---|---|
Gender | 0.005 | 0.672 | |||||
Female | 60 (23.4%) | 36 (18.8%) | 24 (36.9%) | 16 (21.1%) | 44 (24.4%) | ||
Male | 196 (76.6%) | 155 (81.2%) | 41 (63.1%) | 60 (78.9%) | 136 (75.6%) | ||
Age (years) | < 0.001 | 0.664 | |||||
< 50 | 71 (27.7%) | 65 (34.0%) | 6 (9.23%) | 23 (30.3%) | 48 (26.7%) | ||
≥ 50 | 185 (72.3%) | 126 (66.0%) | 59 (90.8%) | 53 (69.7%) | 132 (73.3%) | ||
Hypertension | 0.697 | 0.209 | |||||
No | 184 (71.9%) | 139 (72.8%) | 45 (69.2%) | 50 (65.8%) | 134 (74.4%) | ||
Yes | 72 (28.1%) | 52 (27.2%) | 20 (30.8%) | 26 (34.2%) | 46 (25.6%) | ||
Coronary Heart Disease | 0.864 | 0.525 | |||||
No | 233 (91.0%) | 173 (90.6%) | 60 (92.3%) | 71 (93.4%) | 162 (90.0%) | ||
Yes | 23 (8.98%) | 18 (9.42%) | 5 (7.69%) | 5 (6.58%) | 18 (10.0%) | ||
Diabetes | 0.202 | 0.564 | |||||
No | 242 (94.5%) | 183 (95.8%) | 59 (90.8%) | 71 (93.4%) | 171 (95.0%) | ||
Yes | 14 (5.47%) | 8 (4.19%) | 6 (9.23%) | 5 (6.58%) | 9 (5.00%) | ||
Cerebral Infarction | 0.087 | 1.000 | |||||
No | 238 (93.0%) | 181 (94.8%) | 57 (87.7%) | 71 (93.4%) | 167 (92.8%) | ||
Yes | 18 (7.03%) | 10 (5.24%) | 8 (12.3%) | 5 (6.58%) | 13 (7.22%) | ||
Duration of Incarcerated Inguinal Hernia (h) | < 0.001 | 0.876 | |||||
< 12 | 148 (57.8%) | 133 (69.6%) | 15 (23.1%) | 45 (59.2%) | 103 (57.2%) | ||
≥ 12 | 108 (42.2%) | 58 (30.4%) | 50 (76.9%) | 31 (40.8%) | 77 (42.8%) | ||
Location of Incarcerated Inguinal Hernia | 0.913 | 0.308 | |||||
Right | 162 (63.3%) | 120 (62.8%) | 42 (64.6%) | 44 (57.9%) | 118 (65.6%) | ||
Left | 94 (36.7%) | 71 (37.2%) | 23 (35.4%) | 32 (42.1%) | 62 (34.4%) | ||
Size of Incarcerated Inguinal Hernia (cm) | 0.727 | 0.494 | |||||
< 5*5 | 168 (65.6%) | 127 (66.5%) | 41 (63.1%) | 47 (61.8%) | 121 (67.2%) | ||
≥ 5*5 | 88 (34.4%) | 64 (33.5%) | 24 (36.9%) | 29 (38.2%) | 59 (32.8%) | ||
Pneumoperitoneum | 0.001 | 0.635 | |||||
No | 251 (98.0%) | 191 (100%) | 60 (92.3%) | 74 (97.4%) | 177 (98.3%) | ||
Yes | 5 (1.95%) | 0 (0.00%) | 5 (7.69%) | 2 (2.63%) | 3 (1.67%) | ||
Rebound Tenderness | < 0.001 | 0.723 | |||||
No | 230 (89.8%) | 183 (95.8%) | 47 (72.3%) | 67 (88.2%) | 163 (90.6%) | ||
Yes | 26 (10.2%) | 8 (4.19%) | 18 (27.7%) | 9 (11.8%) | 17 (9.44%) | ||
Board like Rigidity of the Aabdomen | < 0.001 | 0.895 | |||||
No | 235 (91.8%) | 185 (96.9%) | 50 (76.9%) | 69 (90.8%) | 166 (92.2%) | ||
Yes | 21 (8.20%) | 6 (3.14%) | 15 (23.1%) | 7 (9.21%) | 14 (7.78%) | ||
Hernia Sac Effusion | < 0.001 | 1.000 | |||||
No | 190 (74.2%) | 182 (95.3%) | 8 (12.3%) | 56 (73.7%) | 134 (74.4%) | ||
Yes | 66 (25.8%) | 9 (4.71%) | 57 (87.7%) | 20 (26.3%) | 46 (25.6%) | ||
Abdominal effusion | < 0.001 | 0.216 | |||||
No | 221 (86.3%) | 189 (99.0%) | 32 (49.2%) | 62 (81.6%) | 159 (88.3%) | ||
Yes | 35 (13.7%) | 2 (1.05%) | 33 (50.8%) | 14 (18.4%) | 21 (11.7%) | ||
Surgical Procedure | 0.001 | 0.571 | |||||
Open | 212 (82.8%) | 149 (78.0%) | 63 (96.9%) | 65 (85.5%) | 147 (81.7%) | ||
Laporoscopy | 44 (17.2%) | 42 (22.0%) | 2 (3.08%) | 11 (14.5%) | 33 (18.3%) | ||
Incision Site | < 0.001 | 0.214 | |||||
Inguinal incision | 215 (84.0%) | 180 (94.2%) | 35 (53.8%) | 60 (78.9%) | 155 (86.1%) | ||
Abdominal incision | 41 (16.0%) | 11 (5.76%) | 30 (46.2%) | 16 (21.1%) | 25 (13.9%) | ||
Hernia Mesh | < 0.001 | 0.587 | |||||
No | 173 (67.6%) | 112 (58.6%) | 61 (93.8%) | 49 (64.5%) | 124 (68.9%) | ||
Yes | 83 (32.4%) | 79 (41.4%) | 4 (6.15%) | 27 (35.5%) | 56 (31.1%) | ||
White Blood Cell (109/l) | < 0.001 | 0.255 | |||||
≤ 10 | 177 (69.1%) | 145 (75.9%) | 32 (49.2%) | 49 (64.5%) | 128 (71.1%) | ||
10 < White Blood Cell < 20 | 67 (26.2%) | 45 (23.6%) | 22 (33.8%) | 21 (27.6%) | 46 (25.6%) | ||
≥ 20 | 12 (4.69%) | 1 (0.52%) | 11 (16.9%) | 6 (7.89%) | 6 (3.33%) | ||
Hemoglobin (g/l) | 0.613 | 0.207 | |||||
< 130 | 125 (48.8%) | 91 (47.6%) | 34 (52.3%) | 32 (42.1%) | 93 (51.7%) | ||
≥ 130 | 131 (51.2%) | 100 (52.4%) | 31 (47.7%) | 44 (57.9%) | 87 (48.3%) | ||
Platelet (109/l) | 0.025 | 0.419 | |||||
< 300 | 206 (80.5%) | 147 (77.0%) | 59 (90.8%) | 64 (84.2%) | 142 (78.9%) | ||
≥ 300 | 50 (19.5%) | 44 (23.0%) | 6 (9.23%) | 12 (15.8%) | 38 (21.1%) | ||
Procalcitonin (g/l) | < 0.001 | 0.958 | |||||
< 0.05 | 183 (71.5%) | 170 (89.0%) | 13 (20.0%) | 55 (72.4%) | 128 (71.1%) | ||
≥ 0.05 | 73 (28.5%) | 21 (11.0%) | 52 (80.0%) | 21 (27.6%) | 52 (28.9%) | ||
Neutrophil Ratio (%) | < 0.001 | 0.270 | |||||
< 90 | 223 (87.1%) | 179 (93.7%) | 44 (67.7%) | 63 (82.9%) | 160 (88.9%) | ||
≥ 90 | 33 (12.9%) | 12 (6.28%) | 21 (32.3%) | 13 (17.1%) | 20 (11.1%) | ||
Prothrombin Time (s) | < 0.001 | 0.471 | |||||
< 14 | 175 (68.4%) | 146 (76.4%) | 29 (44.6%) | 49 (64.5%) | 126 (70.0%) | ||
≥ 14 | 81 (31.6%) | 45 (23.6%) | 36 (55.4%) | 27 (35.5%) | 54 (30.0%) | ||
Fibrinogen Concentration (g/l) | < 0.001 | 1.000 | |||||
< 4 | 193 (75.4%) | 155 (81.2%) | 38 (58.5%) | 57 (75.0%) | 136 (75.6%) | ||
≥ 4 | 63 (24.6%) | 36 (18.8%) | 27 (41.5%) | 19 (25.0%) | 44 (24.4%) |